diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: subjects with HbA1c 5.5 to 6.4 % or fasting plasma glucose 100 to 125 mg/dL in the last 1 year check-up
Exclusion criteria
Exclusion criteria: subjects with HbA1c >=6.5 or fasting plasma glucose >=126mg/dL diabetes patients under treatment patients with severe constipation subjects have allergy allergy for wheat or soy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| plasma glucose elevation | — |
Countries
Japan
Contacts
Gunma University Hospital Department of Clinical Laboratory Medicine